Delivery Order SPE2DB22D3401-SPE2DB24FT4AJ

Award Date 7/31/24
Potential Completion Date 8/1/24
Potential Value $9.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,724.97 firm fixed-price delivery order is for the supply of Latuda 40 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (doing business as Amerisourcebergen) and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026....
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Latuda 80 mg tablets, a specialty pharmaceutical product. The contract has a ceiling value of $4,943.14 and a period of performance through October 26, 2023. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,438.88 firm fixed-price delivery order is for the supply of Latuda 40 mg tablets. The contract has an ultimate completion date of April 15, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of the prescription medication Latuda 40 mg tablets. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by the parent company Cencora, Inc. (doing business as Amerisourcebergen) with the Defense Logistics Agency (DLA) Troop Support Medical. This IDC serves as the primary vehicle for...
This federal contract award, valued at $1,710.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Latuda 40 mg tablets and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,575.82 firm fixed-price delivery order contract is for the supply of Latuda 80 mg tablets to support federal healthcare programs. The contract is not designated with a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award is between the Defense Logistics Agency (DLA) and Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Latuda 40 mg tablet 30s. The $5,592.70 firm fixed-price delivery order is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract, which does...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,948.76 fixed-price delivery order is for the supply of Latuda 80 mg tablets, a pharmaceutical product used in the treatment of mental health conditions. The contract has an ultimate completion date of January 21, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,798.40, is for the delivery of Latuda 40 mg tablets. It is a firm fixed-price delivery order contract that runs through September 2024. The contract is not designated as a set-aside award. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The award is for the delivery of Latuda 40 mg tablets, a specialty pharmaceutical product, with a ceiling value of $2,035.74 and a performance period through April 2, 2024. This award is a delivery order contract, with a firm fixed price pricing type, and does not have a set-aside...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB24FT4AJ
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of Latuda 40 mg tablets. The award, valued at $9,218.17, is for a Firm Fixed Price Delivery Order with an ultimate completion date of August 1, 2024. This appears to be a part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025 between the DLA Troop Support Medical and Amerisourcebergen, which enables the government to efficiently procure a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 10/30/24, 9:03 AM